Discussion
Diagnosis With Brief Discussion
- Diagnosis
- Epithelioid hemangioendothelioma
- Radiologic Findings
- Non-enhanced chest CT images show innumerable and variable-sized (less than 1 cm) nodules in bilateral lungs. These nodules are well-defined, round, and non-calcified. There are no enlarged lymph nodes, pleural effusion, or other relevant pulmonary changes.
Enhanced abdominal CT images show multiple low-attenuating lesions in both hemilivers.
Upon 18F-FDG PET/CT examination, these pulmonary nodules show no remarkable accumulation of the tracer; however, a false negative result cannot be entirely excluded, due to the small size of the nodules. There is no lesion with abnormal increased FDG uptake in the scanned body.
The patient underwent VATS biopsy at the right lower lobe, and pulmonary nodules were confirmed as epithelioid hemangioendotheliomas.
- Brief Review
- Epithelioid hemangioendothelioma (EH) is a rare vascular tumor, originating from vascular endothelial or pre-endothelial cells. This low- to intermediate-grade sarcoma may involve the liver alone (21%), liver and lung (18%), lung alone (12%), or bone alone (14%), and can be aggressive, even resulting in systemic metastasis. Pulmonary EH are four times more common in women than in men and are often detected incidentally. The prognosis is variable, and the 5-year survival probability is 60% (range: 47-71%). There is no established standard treatment of choice; Surgery and/or chemoradiation therapy could be considered, depending on intrathoracic tumor spread and systemic metastases.
Multiple discrete pulmonary nodules are the most common CT finding of pulmonary EH. The nodules range in size up to 2 cm, but most are less than 1 cm in diameter. On serial CT examinations, these lesions show little or no growth. In this form of pulmonary EH, differential diagnosis includes pulmonary metastases, miliary granulomatous infection, sarcoidosis, silicosis, and primary lung malignancy. Other findings of pulmonary EH include multiple reticulonodular opacities mimicking hematolymphangitic metastasis and diffuse infiltrative pleural thickening mimicking malignant pleural mesothelioma or diffuse pleural carcinomatosis.
PET/CT findings can demonstrate increased FDG-uptake but usually are not a pivotal tool for the diagnosis, and a negative PET cannot exclude pulmonary EH. This false negative result is thought to be caused by the small size of the nodules, little FDG activity in the neoplasm, or low cellular density.
In our case, a close follow-up with chest CT was planned. The patient still has no symptoms and has survived for 33 months following the initial diagnosis. On the last chest CT, previous nodules are similar or have slightly increased in size without measurable change.
- References
- 1. Angela Sardaro, Lilia Bardoscia, Maria Fonte Petruzzelli, Maurizio Portaluri : Epithelioid hemangioendothelioma : an overview and update on a rare vascular tumor. Oncology Review 2014; 8:82-91
2. Kenneth Lau, Malek Massad, Cynthia Pollak, Charles Rubin, Joannie Yeh, Jing Wang et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest 2011; 140:1312–1318
3. Eun Young Kim, Tae Sung Kim, Joungho Han, Joon Young Choi, O Jung Kwon and Jhingook Kim : Thoracic epithelioid hemangioendothelioma. Acta Radiologica 2011; 52: 161-166
4. Kyung Soo Lee, Joungho Han, Man Pyo Chung, Yeon Joo Jeong. Radiology Illustrated: Chest Radiology, Verlag Berlin Heidelberg: Springer, 2014:190
5. Jung Han Han, Tae Jung Kim, Kyung Soo Lee, Tae Sung Kim, Byung-Tae Kim : Epithelioid hemangioendothelioma in the thorax: Clinicopathologic, CT, PET, and prognostic features. Medicine 2016; 95: 30
- Please refer to
- Case 1088 Case 932 Case 772 Case 762 Case 691 Case 649
-
- Keywords
- Lung, Neoplasm,